Horellou M H, Conard J, Bertina R M, Samama M
Br Med J (Clin Res Ed). 1984 Nov 10;289(6454):1285-7. doi: 10.1136/bmj.289.6454.1285.
Investigation of 118 patients for protein C deficiency using an immunological and a functional assay, and subsequent investigation of those (nine) found to be deficient, identified 22 patients (14 women, eight men) with protein C deficiency, of whom six were asymptomatic, 15 had histories of venous thromboembolism, and one had a history of arterial thromboembolism. Protein C deficiency was associated in the nine probands with young age at first episode of thromboembolic disease (mean 24.1 (SD 11.9) years), absence of a precipitating condition (five (56%], and a family history of thromboembolic disease (six (66%]. Investigation of the nine families suggested autosomal dominant transmission of the defect. Thromboembolic episodes were seen in patients with protein C antigen concentrations below 0.6 U/ml. Mean (SD) protein C antigen concentrations were 0.48 (0.12) U/ml in 18 patients not receiving oral anticoagulant treatment and 0.28 (0.05) U/ml in four receiving such treatment. One patient with severe protein C deficiency (0.16 U/ml) developed skin necrosis soon after starting oral anticoagulant treatment.
采用免疫测定法和功能测定法对118例患者进行蛋白C缺乏症调查,随后对其中9例被发现缺乏蛋白C的患者进行进一步调查,共确定了22例(14名女性,8名男性)蛋白C缺乏症患者,其中6例无症状,15例有静脉血栓栓塞病史,1例有动脉血栓栓塞病史。9名先证者的蛋白C缺乏症与血栓栓塞性疾病首次发作时年龄较轻(平均24.1(标准差11.9)岁)、无诱发因素(5例(56%))以及有血栓栓塞性疾病家族史(6例(66%))有关。对这9个家族的调查提示该缺陷为常染色体显性遗传。蛋白C抗原浓度低于0.6 U/ml的患者出现了血栓栓塞发作。18例未接受口服抗凝治疗的患者的蛋白C抗原平均(标准差)浓度为0.48(0.12)U/ml,4例接受口服抗凝治疗的患者的蛋白C抗原平均(标准差)浓度为0.28(0.05)U/ml。1例蛋白C严重缺乏(0.16 U/ml)的患者在开始口服抗凝治疗后不久出现了皮肤坏死。